These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 28968574)

  • 1. Spectroflurimetric estimation of the new antiviral agent ledipasvir in presence of sofosbuvir.
    Salama FM; Attia KA; Abouserie AA; El-Olemy A; Abolmagd E
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Feb; 190():513-517. PubMed ID: 28968574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of the brand new two-drug combination for the treatment of hepatitis C: Sofosbuvir/ledipasvir using smart spectrophotometric methods manipulating ratio spectra.
    Eissa MS
    Spectrochim Acta A Mol Biomol Spectrosc; 2017 Aug; 183():362-370. PubMed ID: 28460317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Earth-friendly spectrophotometric methods for simultaneous determination of ledipasvir and sofosbuvir: Application to average content and uniformity of dosage unit testing.
    El-Shorbagy HI; Elsebaei F; Hammad SF; Elbrashy AM
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Dec; 205():398-409. PubMed ID: 30044997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validated spectrophotometric and chromatographic methods for analysis of the recently approved hepatitis C antiviral combination ledipasvir and sofosbuvir.
    Baker MM; El-Kafrawy DS; Mahrous MS; Belal TS
    Ann Pharm Fr; 2018 Jan; 76(1):16-31. PubMed ID: 28842163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific stability indicating spectrofluorimetric method for determination of ledipasvir in the presence of its confirmed degradation products; application in human plasma.
    Ali R; Marzouk AA; Abdelhameid RA; Omar MA
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Sep; 202():50-57. PubMed ID: 29777934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a highly sensitive high-performance thin-layer chromatography method for the screening and simultaneous determination of sofosbuvir, daclatasvir, and ledipasvir in their pure forms and their different pharmaceutical formulations.
    Saraya RE; Elhenawee M; Saleh H
    J Sep Sci; 2018 Sep; 41(18):3553-3560. PubMed ID: 30048040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new innovative spectrophotometric method for the simultaneous determination of sofosbuvir and ledipasvir.
    Mansour FR
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Jan; 188():626-632. PubMed ID: 28783604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovative Thin-Layer Chromatography/Fluorescence Detection Approach for Sensitive and Specific Determination of Ledipasvir in Rats' Feces and Pharmaceutical Dosage Form.
    Abdel-Lateef MA; Omar MA; Ali R; Almahri A; Derayea SM
    J Chromatogr Sci; 2021 Jun; 59(7):634-641. PubMed ID: 33634316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemometric simultaneous determination of Sofosbuvir and Ledipasvir in pharmaceutical dosage form.
    Khalili M; Sohrabi MR; Mirzabeygi V; Torabi Ziaratgahi N
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Apr; 194():141-151. PubMed ID: 29331815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a versatile HPLC-DAD method for simultaneous determination of the antiviral drugs daclatasvir, ledipasvir, sofosbuvir and ribavirin in presence of seven potential impurities. Application to assay of dosage forms and dissolution studies.
    Baker MM; Hammad SF; Belal TS
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1111-1119. PubMed ID: 30929537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micellar-based spectrofluorimetric method for the selective determination of ledipasvir in the presence of sofosbuvir: application to dosage forms and human plasma.
    Abdel-Lateef MA; Ali R; Omar MA; Derayea SM
    Luminescence; 2020 Jun; 35(4):486-492. PubMed ID: 31869004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemometrically Assisted Development of Ultra-High-Performance Liquid Chromatography Method for the Simultaneous Quantification of Sofosbuvir, Daclatasvir and Ledipasvir in Pharmaceutical Dosage Forms.
    Labidi A; El Atrache LL
    J Chromatogr Sci; 2020 Jan; 57(10):910-919. PubMed ID: 31644804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrophotometric Methods for Simultaneous Determination of Sofosbuvir and Ledipasvir (HARVONI Tablet): Comparative Study with Two Generic Products.
    Abo-Talib NF; El-Ghobashy MR; Tammam MH
    J AOAC Int; 2017 Jul; 100(4):976-984. PubMed ID: 28330530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of colorimetric-assisted chemometrics methods based on the localized gold nanoparticles surface plasmon resonance for fast simultaneous estimation of anti-hepatitis C virus drugs in their combined dosage form: A comparative study with HPLC method.
    Naeimi MS; Sohrabi MR; Mortazavinik S
    J Pharm Biomed Anal; 2024 Sep; 248():116300. PubMed ID: 38924879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated Reversed-Phase Liquid Chromatographic Method with Gradient Elution for Simultaneous Determination of the Antiviral Agents: Sofosbuvir, Ledipasvir, Daclatasvir, and Simeprevir in Their Dosage Forms.
    Ezzeldin E; Abo-Talib NF; Tammam MH; Asiri YA; Amr AEE; Almehizia AA
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33050433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between core-shell and totally porous particle stationary phases for fast and green LC determination of five hepatitis-C antiviral drugs.
    Ibrahim AE; Hashem H; Elhenawee M; Saleh H
    J Sep Sci; 2018 Apr; 41(8):1734-1742. PubMed ID: 29297968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of a sensitive and robust strategy for micellar electrokinetic chromatographic analysis of sofosbuvir in combination with its co-formulated hepatitis C antiviral drugs.
    Rageh AH; Abdel-Aal FAM; Pyell U
    J Chromatogr A; 2020 Apr; 1616():460795. PubMed ID: 31918849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantification of simeprevir sodium: A hepatitis C protease inhibitor in binary and ternary mixtures with sofosbuvir and/or ledipasvir utilizing direct and H-point standard addition strategies.
    Mohamed SH; Issa YM; Salim AI
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 Mar; 210():290-297. PubMed ID: 30469132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive spectrofluorimetric method for rapid determination of daclatasvir and ledipasvir in human plasma and pharmaceutical formulations.
    Abo-Zeid MN; Atia NN; El-Gizawy SM; El-Shaboury SR
    J Pharm Biomed Anal; 2018 Apr; 152():155-164. PubMed ID: 29414007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous determination of ledipasvir, sofosbuvir and its metabolite in rat plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
    Pan C; Chen Y; Chen W; Zhou G; Jin L; Zheng Y; Lin W; Pan Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jan; 1008():255-259. PubMed ID: 26684720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.